Educating Diabetes Healthcare Professionals Worldwide
NEWS |
|
LIVE WEBINARS.
Sign up today to participate in one of our interactive webinars at no charge and gain enhanced insights into Medtronic diabetes products.
Can’t make a live event? Browse our selection of recently recorded events.
Professional CGM reimbursement interactive
insight tool.
Learn more about potential clinical & economic benefits of Professional CGM for your practice.
- Medicare Reimbursement Rates
- Commercial Payer Policies
- Sample Economic Model
ResourceLibrary.
Select from a variety of resource materials that you can download and share with your patients and practice.
What information can we help you find today?
I want to learn more about the latest advancements in insulin pump therapy.
AUTOMATICALLY ADJUSTS TO YOUR PATIENT'S LIFE.
Insulin pump therapy provides more flexibility for your patients’ lifestyle while giving them greater control of their diabetes. The MiniMed™ 670G insulin pump system is revolutionary new technology that mimics some of the functions of a healthy pancreas.
90%§
of users reported that the MiniMed™ 670G system met expectations for improved overall health.
HOW INSULIN PUMP THERAPY WORKS.
HOW TO GET PATIENTS STARTED ON INSULIN PUMP THERAPY.
Best practices overview for initiating patients on the pump.
I am looking for smart CGM solutions for my patients currently on multiple daily injections.
SMART CGM FOR PATIENTS ON MDI.
Now your patients may experience fewer lows and highs. The Guardian™ Connect CGM system monitors glucose levels day and night, sending precise readings automatically to the app. The system includes a small sensor, Guardian™ Sensor 3, that can be worn up to seven days and a slim, discreet Bluetooth® transmitter that can be worn in almost any situation. They work together to send precise glucose readings every five minutes.
SUGAR.IQ™ PERSONAL DIABETES ASSISTANT.
Help patients understand their daily glucose patterns and identify activities affecting them — for a full picture of their diabetes.†
GUARDIAN™ CONNECT CGM SYSTEM.
The clearly smarter way to help patients experience fewer highs and lows.
The only CGM system that can alert your patients of potential highs and lows up to 60 minutes in advance.
AUTOMATIC UPLOADS TO CARELINK™ SYSTEM.
Seamlessly and conveniently access your patients daily sensor glucose readings directly from your practice.
I am seeking tools that will allow me and my patients to visualize diabetes information with simple charts and statistics.
COMPREHENSIVE INSIGHTS FOR WELL-INFORMED DECISIONS. CARELINK™ REPORTS.
CareLink™ reports help you visualize your patient’s diabetes information with charts and statistics; making your job easier. The data is delivered in a way to help you make recommendations you are confident about. CareLink™ reports intelligently analyze all the data to highlight observations and patterns.
HOW CARELINK™ SYSTEM WORKS.
87%
of clinical diabetes educators choose CareLink™ as their preferred diabetes software∆ .
DO A QUICK CHECK OR TAKE A DEEP DIVE.
With an array of new reports, CareLink™ software makes it easier than ever to quickly assess and track your patients progress.
iPro™2 professional CGM evaluation.
Easily interpret patient CGM data with simple CareLink™ iPro™ Pattern Snapshot reports.
1. Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Prrukcheewanont P: A pilot study of the continuous glucose monitoring system, Diabetes Care. 2001;24(12):2030−2034 2. Compared to self-monitored blood glucose alone.
† The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.
∆ dQ&A Diabetes Educator Perspectives Survey, Q3 2015. 428 total respondents.
§ Customer training phase – data on file.
# Data on File. Data from CareLink™ personal software uploads in the US from March 2017 to May 2019; patient days = 6,285,416. 212,173 total predicted hypo events avoided in April 2019. Lows refers to sensor glucose values < 70mg/dL. Highs refers to sensor glucose values > 180 mg/dL.
Φ The patient testimonial above relates an account of an individual’s response to treatment. The account is genuine, typical and documented. However, this patient’s response does not provide any indication, guide, warranty or guarantee as to the response other people may have to the treatment. The response other individuals have to the treatment could be different. Responses to the treatment can and do vary. Not every response is the same. Please talk to your doctor about your condition and the risks and benefits of these technologies.